Login to Your Account



FDA lays out a plan to step up PRD drug development

By Mari Serebrov
Washington Editor

Thursday, July 10, 2014
Keeping up with its obligations under the FDA Safety and Innovation Act (FDASIA), the FDA issued its strategic plan for accelerating the development of drugs and medical devices to treat rare diseases in children.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription